Public Company

Cipla to raise Rs 1,500 cr by issue of shares

Drug maker Cipla today said it will raise Rs 1,500 crore from international market by issue of securities. - SC refuses relief to Roche on patent plea against Cipla - Drug to treat swine flu to be available in retail mkt - JB Chemicals gets USFDA nod for its anti-allergic tablets - Cipla gains 3% on capex plan - GSK to launch "promecta" in India by 2009-end - Aurobindo Pharma receives Swissmedic approval for cefepime for injection The shareholders have approved raising Rs 1,500 crore by issuing non-convertible debentures, Foreign Currency Convertible Bonds, American Depository Receipts and Global Depository Receipts, Cipla said in a filing to the Bombay Stock Exchange. The proposal is subjected to necessary regulatory approvals, the filing added. Shares of Cipla today closed at Rs 272.30 on BSE, up 0.91 per cent from the previous close.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

Categories
Business Ideas
Business Opportunities
Corporate
Home Business
International Business
Management
Online Business
Public Company
Public Relations
Small Business
News of the day
IIM-A director in touch with other IIMs on CAT
The director of Indian Institute of Management, Ahmedabad (IIM-A) is constantly in touch with his counterparts in other IIMs to solve problems regarding the first computer-based CAT (Common Admission Test), institute officials said here today.
Popular Articles

Statistical lie
In a country where data and information flow is like water on the Moon, bankers who are smart often take advantage of a statistical lie. “When I was a general manager in the planning department, I used to say come to me, I will give all the information.

RNRL renews attack
Anil Ambani-controlled RNRL told the Supreme Court today that Mukesh Ambani’s RIL had put it in a disadvantageous position in terms of price, quantity and tenure in their Gas Supply Master Agreement (GSMA).

© Copyright 2009